Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism MAPK13 inhibitors(mitogen-activated protein kinase 13 inhibitors), p38α inhibitors(P38 α mitogen-activated protein kinase inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |
Molecular FormulaC65H69F2N7O12S |
InChIKeyLVQCYBJKHQGJSR-LVSOZEIGSA-N |
CAS Registry- |